SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: kech who wrote (860)7/21/1999 6:58:00 PM
From: John Metcalf  Respond to of 2001
 
ADCON should be expected to have a lumpy roll-out, because the product is sold to hospitals. The last quarterly statement indicated a significant increase in hospitals (16% or so). These users would not yet be on a predictable re-order basis, having just bought initial stock. Further, some lag in adoption within each hospital should be expected, and new users may take a little time, looking at results before they develop a commitment to the product. In a quarter or two, re-orders from the larger base should be booked.



To: kech who wrote (860)7/21/1999 9:48:00 PM
From: LLCF  Read Replies (1) | Respond to of 2001
 
11% sounds ok but when the year to year comparisons are 14x (.5 to 7 million) you might have hoped that something like 100% growth would continue which would be more like 25% sequential growth. In some circumstances 11% might seem slow.>

Actually 19% sequential per quarter is 100% per year... 11% sequential sind... hmmm... mach das... ungefahr: 52% per annum.

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News